These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 39025928)

  • 21. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
    Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
    J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time.
    Shuangshoti S; Tadadontip P; Techavichit P; Thorner PS; Shuangshoti S; Teerapakpinyo C
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):538-543. PubMed ID: 31343993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analysis of HOXA10 and HOXB4 in human medulloblastoma cell lines.
    Bonfim-Silva R; Ferreira Melo FU; Thomé CH; Abraham KJ; De Souza FAL; Ramalho FS; Machado HR; De Oliveira RS; Cardoso AA; Covas DT; Fontes AM
    Int J Oncol; 2017 Dec; 51(6):1929-1940. PubMed ID: 29039487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the enhancer of zeste homologue 2 in medulloblastoma.
    Alimova I; Venkataraman S; Harris P; Marquez VE; Northcott PA; Dubuc A; Taylor MD; Foreman NK; Vibhakar R
    Int J Cancer; 2012 Oct; 131(8):1800-9. PubMed ID: 22287205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medulloblastoma stem cells.
    Fan X; Eberhart CG
    J Clin Oncol; 2008 Jun; 26(17):2821-7. PubMed ID: 18539960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
    Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
    Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medulloblastoma stem cells: modeling tumor heterogeneity.
    Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK
    Cancer Lett; 2013 Sep; 338(1):23-31. PubMed ID: 22796365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early rhombic lip Protogenin
    Visvanathan A; Saulnier O; Chen C; Haldipur P; Orisme W; Delaidelli A; Shin S; Millman J; Bryant A; Abeysundara N; Wu X; Hendrikse LD; Patil V; Bashardanesh Z; Golser J; Livingston BG; Nakashima T; Funakoshi Y; Ong W; Rasnitsyn A; Aldinger KA; Richman CM; Van Ommeren R; Lee JJY; Ly M; Vladoiu MC; Kharas K; Balin P; Erickson AW; Fong V; Zhang J; Suárez RA; Wang H; Huang N; Pallota JG; Douglas T; Haapasalo J; Razavi F; Silvestri E; Sirbu O; Worme S; Kameda-Smith MM; Wu X; Daniels C; MichaelRaj AK; Bhaduri A; Schramek D; Suzuki H; Garzia L; Ahmed N; Kleinman CL; Stein LD; Dirks P; Dunham C; Jabado N; Rich JN; Li W; Sorensen PH; Wechsler-Reya RJ; Weiss WA; Millen KJ; Ellison DW; Dimitrov DS; Taylor MD
    Cell; 2024 Aug; 187(17):4733-4750.e26. PubMed ID: 38971152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164.
    Shi JA; Lu DL; Huang X; Tan W
    Int J Mol Med; 2014 Jul; 34(1):237-43. PubMed ID: 24756834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation.
    Liu H; Sun Q; Sun Y; Zhang J; Yuan H; Pang S; Qi X; Wang H; Zhang M; Zhang H; Yu C; Gu C
    Mol Cancer Res; 2017 Sep; 15(9):1275-1286. PubMed ID: 28536141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microarray discovery of new OGT substrates: the medulloblastoma oncogene OTX2 is O-GlcNAcylated.
    Ortiz-Meoz RF; Merbl Y; Kirschner MW; Walker S
    J Am Chem Soc; 2014 Apr; 136(13):4845-8. PubMed ID: 24580054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
    Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
    PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.
    Panwalkar P; Moiyadi A; Goel A; Shetty P; Goel N; Sridhar E; Shirsat N
    J Mol Neurosci; 2015 Jul; 56(3):673-80. PubMed ID: 25859932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma.
    Ahmad Z; Jasnos L; Gil V; Howell L; Hallsworth A; Petrie K; Sawado T; Chesler L
    PLoS One; 2015; 10(3):e0119834. PubMed ID: 25785590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes.
    Morrison LC; McClelland R; Aiken C; Bridges M; Liang L; Wang X; Di Curzio D; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
    Neoplasia; 2013 Apr; 15(4):384-98. PubMed ID: 23555184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.
    Di C; Liao S; Adamson DC; Parrett TJ; Broderick DK; Shi Q; Lengauer C; Cummins JM; Velculescu VE; Fults DW; McLendon RE; Bigner DD; Yan H
    Cancer Res; 2005 Feb; 65(3):919-24. PubMed ID: 15705891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.
    Wang S; Zhang D; Wang J; Peng X; Sun H; Ji Y; Yang Z; Bian X; Hou Y; Ge M; Liu Y
    J Neurooncol; 2024 May; 168(1):139-149. PubMed ID: 38662151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas.
    Bai R; Siu IM; Tyler BM; Staedtke V; Gallia GL; Riggins GJ
    Neuro Oncol; 2010 Jul; 12(7):655-63. PubMed ID: 20511190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.
    de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.